Perturbation to dose distribution caused by utilizing an MLC instead of a brass aperture in passive scattering proton therapy

被引:0
|
作者
Goulart, D. [1 ]
Maughan, R. [1 ]
McDonough, J. [1 ]
Bloch, P. [1 ]
Avery, S. [1 ]
Ainsley, C. [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
10.1118/1.2761008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the perturbation to dose distribution caused by utilizing a tungsten MLC instead of a brass aperture in passive scattering proton therapy. Method and Materials: A four‐dimensional GEANT4 Monte Carlo simulation of a proton therapy nozzle is used to simulate the behavior of a beam delivery system. Several datasets have been generated accounting for different configurations of system components including binary pre‐scatterer foils, double contoured scatterer, modulator wheel, and pre‐collimator jaws. The resulting beam profiles are subject to one of two different final collimator options: a tungsten MLC or a brass aperture. The performance of the beam delivery system is examined for different beam energies, intensity modulation patterns, field size, air gap between the MLC and the patient, and the introduction of a step in the design of the MLC. Results: We quantify dosimetric perturbations when conforming to a simple target volume. Variations in several factors were studied, including lateral field flatness and symmetry, penumbra, and flatness of the spread‐out Bragg peak. When compared to results obtained using a brass aperture, an MLC made of tungsten seems to produce similar results. Additionally, the respective neutron energy distributions were used to calculate the neutron equivalent dose absorbed outside of the treatment field in each case. Conclusion: The ability of an MLC to conform to target volume is a function of the specific contour shape. This is not necessarily true for a custom made aperture. However, our analysis of dosimetric differences between the two indicates that there are no significant differences for simple target volume contours. The performance of an MLC as a final collimator in passive scattering proton therapy is predicted to be comparable to the performance of a brass aperture. Furthermore, secondary neutron production is reduced by using a tungsten MLC rather than a brass aperture. © 2007, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:2481 / 2481
页数:1
相关论文
共 32 条
  • [1] Comparison of Dose Distributions Between Two Arrangements of a Range Compensator and of An Aperture Collimator in a Passive Scattering Method for Proton Therapy
    Hotta, K.
    Kohno, R.
    Takada, Y.
    Hara, Y.
    Tansho, R.
    MEDICAL PHYSICS, 2011, 38 (06) : 3568 - +
  • [2] Dose Evaluation From Scattered Protons in Passive Scattering Proton Therapy
    Kim, C.
    Lee, N.
    Lee, S.
    Jeong, J.
    Kim, H.
    Shin, D.
    Lim, Y.
    Shin, W.
    Min, C.
    MEDICAL PHYSICS, 2018, 45 (06) : E259 - E260
  • [3] Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system
    Diffenderfer, Eric S.
    Ainsley, Christopher G.
    Kirk, Maura L.
    McDonough, James E.
    Maughan, Richard L.
    MEDICAL PHYSICS, 2011, 38 (11) : 6248 - 6256
  • [4] Monte Carlo Dose Verification of Passive Scattering Proton Therapy for Prostate Cancer
    Giantsoudi, D.
    Paganetti, H.
    MEDICAL PHYSICS, 2012, 39 (06) : 3819 - 3819
  • [5] Reduction of superficial radiation dose with bolus in passive scattering proton beam therapy
    Kim, Yeon-Joo
    Kim, Chankyu
    Lee, Se Byeong
    Kim, Jae-Sung
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (02): : 69 - 76
  • [6] Dose perturbation caused by metallic port in breast tissue expander in proton beam therapy
    Zhao, Li
    Moskvin, Vadim M.
    Cheng, Chee-Wai
    Das, Indra J.
    BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2020, 6 (06)
  • [7] Monte Carlo study of neutron dose equivalent during passive scattering proton therapy
    Zheng, Yuanshui
    Newhauser, Wayne
    Fontenot, Jonas
    Taddei, Phil
    Mohan, Radhe
    PHYSICS IN MEDICINE AND BIOLOGY, 2007, 52 (15): : 4481 - 4496
  • [8] Effect of DIR uncertainty on prostate passive-scattering proton therapy dose accumulation
    Abe, Yoshitomo
    Kadoya, Noriyuki
    Arai, Kazuhiro
    Takayama, Yoshiki
    Kato, Takahiro
    Kimura, Kanako
    Ono, Takashi
    Nakamura, Tatsuya
    Wada, Hitoshi
    Kikuchi, Yasuhiro
    Jingu, Keiichi
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 39 : 113 - 120
  • [9] Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC)
    Tayama, Ryuichi
    Fujita, Yasuo
    Tadokoro, Masahiro
    Fujimaki, Hisataka
    Sakae, Takeji
    Terunuma, Toshiyuki
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2006, 564 (01): : 532 - 536
  • [10] Quantification of Dose Uncertainties in DIR-Based Accumulated Dose Estimation On Prostate Passive-Scattering Proton Therapy
    Abe, Y.
    Kadoya, N.
    Arai, K.
    Takayama, Y.
    Kato, T.
    Kimura, K.
    Ono, T.
    Nakamura, T.
    Wada, H.
    Kikuchi, Y.
    Jingu, K.
    MEDICAL PHYSICS, 2017, 44 (06) : 3123 - 3123